Mounjaro price in Korea, explained step by step

What shapes the Mounjaro price in Korea

Mounjaro is the brand name of tirzepatide, a once-weekly injection that activates two gut hormone receptors, GIP and GLP-1. It was launched in Korea in 2025. When you look into the Mounjaro price in Korea, the most important thing to understand is that tirzepatide is prescribed in several strengths, and the strength you need changes over the first months of treatment.

At VEI Clinic, your quote is built from the parts of care you actually receive. Dr. HyunSung Park, an internal medicine specialist, first confirms whether tirzepatide is a safe and sensible choice for you, then explains the expected cost of the medicine and the medical support around it.

• Dose strength: each step from 2.5 mg upward is a different product strength, and price generally differs by strength
• Number of pens or doses: based on how many weeks your plan covers between visits
• Consultation and injection training at the start
• Baseline tests such as blood sugar, HbA1c, lipids, liver and kidney function, and a body composition test where relevant
• Follow-up reviews to adjust your dose and manage side effects

The tirzepatide dose ladder and your budget

Tirzepatide treatment starts at 2.5 mg once weekly for four weeks. This first dose mainly helps your body adjust and is not intended as the long-term treatment dose. After that, the dose can increase in 2.5 mg steps, at least four weeks apart: 5 mg, 7.5 mg, 10 mg, 12.5 mg and up to a maximum of 15 mg.

Many people do not need to climb all the way. If you are losing weight steadily at 5 mg or 10 mg and tolerating it well, staying there may be the right decision. Moving up too quickly increases the risk of nausea, vomiting and diarrhea. This means your monthly cost is not fixed: it reflects the dose that works for you, which we review at each follow-up.

Insurance and paying for Mounjaro

In Korea, tirzepatide used for weight management is generally not covered by the National Health Insurance Service, so it is paid out of pocket. Coverage rules for diabetes treatment are separate and depend on specific criteria. We will tell you clearly which parts of your care, if any, may be handled differently.

For expats with private or international insurance, we can issue itemized receipts and English medical documents to support a claim. Whether your insurer reimburses obesity medicine is up to them, so it is worth checking your policy before starting.

Who should consider Mounjaro, and who should not

Tirzepatide for weight management is generally intended for adults with a BMI of 30 or more, or 27 or more with a weight-related health problem such as high blood pressure, prediabetes, type 2 diabetes, fatty liver or sleep apnea. It may suit people who have tried lifestyle changes without lasting success.

It should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN2, during pregnancy or breastfeeding, or by someone with a history of pancreatitis unless carefully reviewed. Tirzepatide can make oral contraceptives less reliable during the start and after each dose increase, so a backup method is advised during those weeks. If you take insulin or a sulfonylurea, these may need adjusting to prevent low blood sugar.

Limits and safety notes

Tirzepatide is a powerful medicine, but it is not a short fix. Weight regain is common after stopping, so a realistic budget should consider several months of treatment and a plan for what comes after. Common side effects include nausea, diarrhea, constipation, reduced appetite and indigestion, especially after each dose increase.

Seek urgent care, or call 119, if you develop severe stomach pain that may spread to your back, persistent vomiting, signs of dehydration, or symptoms of a serious allergic reaction. Pens bought online or without a prescription may be counterfeit or poorly stored, and we do not recommend them.